Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) have been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $57.40.

Several research analysts have recently commented on ESTA shares. Needham & Company LLC began coverage on Establishment Labs in a research report on Monday, April 14th. They set a “hold” rating for the company. Stephens restated an “overweight” rating and issued a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. raised its holdings in Establishment Labs by 0.4% in the 1st quarter. Raymond James Financial Inc. now owns 119,752 shares of the company’s stock valued at $4,886,000 after acquiring an additional 491 shares during the last quarter. Swiss National Bank boosted its position in Establishment Labs by 1.3% in the 1st quarter. Swiss National Bank now owns 39,000 shares of the company’s stock valued at $1,591,000 after buying an additional 500 shares during the last quarter. Quarry LP purchased a new position in Establishment Labs in the 4th quarter valued at about $27,000. R Squared Ltd purchased a new position in Establishment Labs in the 4th quarter valued at about $36,000. Finally, Federated Hermes Inc. boosted its position in Establishment Labs by 3.0% in the 4th quarter. Federated Hermes Inc. now owns 32,720 shares of the company’s stock valued at $1,507,000 after buying an additional 953 shares during the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Price Performance

Shares of Establishment Labs stock opened at $34.96 on Friday. The business has a 50 day simple moving average of $34.65 and a two-hundred day simple moving average of $38.41. Establishment Labs has a 12 month low of $26.56 and a 12 month high of $60.12. The stock has a market capitalization of $1.01 billion, a P/E ratio of -13.55 and a beta of 0.73. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.83) by $0.13. The business had revenue of $41.38 million during the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The business’s revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.58) earnings per share. As a group, analysts predict that Establishment Labs will post -2.41 EPS for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.